These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 22462645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H.
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [Abstract] [Full Text] [Related]

  • 3. New and emerging drug molecules against obesity.
    George M, Rajaram M, Shanmugam E.
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
    [Abstract] [Full Text] [Related]

  • 4. Emerging pharmacotherapy for obesity.
    Aronne LJ, Powell AG, Apovian CM.
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):587-96. PubMed ID: 21834735
    [Abstract] [Full Text] [Related]

  • 5. Pharmacotherapeutic options for overweight adolescents.
    Dunican KC, Desilets AR, Montalbano JK.
    Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A critical review of the cannabinoid receptor as a drug target for obesity management.
    Akbas F, Gasteyger C, Sjödin A, Astrup A, Larsen TM.
    Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231
    [Abstract] [Full Text] [Related]

  • 13. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG.
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Drug strategies for the treatment of obesity.
    Alemany M, Remesar X, Fernández-López JA.
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [Abstract] [Full Text] [Related]

  • 17. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR, Dhakal-Karki S, Dunican KC.
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [Abstract] [Full Text] [Related]

  • 18. Current and future drug targets in weight management.
    Witkamp RF.
    Pharm Res; 2011 Aug; 28(8):1792-818. PubMed ID: 21181547
    [Abstract] [Full Text] [Related]

  • 19. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
    Gadde KM, Parker CB, Maner LG, Wagner HR, Logue EJ, Drezner MK, Krishnan KR.
    Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy of obesity: emerging drugs and targets.
    Chakrabarti R.
    Expert Opin Ther Targets; 2009 Feb; 13(2):195-207. PubMed ID: 19236237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.